{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:55Z","timestamp":1791583195521,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Moderna, Inc."}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ebiom.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:45:55Z","timestamp":1562892355000},"page":"519-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia"],"prefix":"10.1016","volume":"45","author":[{"given":"Ding","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Frassetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jacquinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Eybye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"DeAntonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Laureano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Sabnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin T.","family":"Guey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.07.003_bb0005","series-title":"GeneReviews(R)","article-title":"Isolated Methylmalonic Acidemia","author":"Manoli","year":"1993"},{"issue":"8","key":"10.1016\/j.ebiom.2019.07.003_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/humu.23013","article-title":"Molecular genetic characterization of 151 Mut-type Methylmalonic aciduria patients and identification of 41 novel mutations in MUT","volume":"37","author":"Forny","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.ebiom.2019.07.003_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10545-011-9426-1","article-title":"Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?","volume":"35","author":"Zwickler","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MOP.0000000000000422","article-title":"Methylmalonic and propionic acidemias: clinical management update","volume":"28","author":"Fraser","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2019.07.003_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/PDR.0b013e3180a0325f","article-title":"Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, Mut-, cblA, cblB)","volume":"62","author":"Horster","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12659\/AOT.883820","article-title":"Children undergoing liver transplantation for treatment of inherited metabolic diseases are prone to higher oxidative stress, complement activity and transforming growth factor-beta1","volume":"18","author":"Hussein","year":"2013","journal-title":"Ann Transplant"},{"issue":"5","key":"10.1016\/j.ebiom.2019.07.003_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1744-9987.2011.00974.x","article-title":"Preoperative dialysis for liver transplantation in methylmalonic acidemia","volume":"15","author":"Kamei","year":"2011","journal-title":"Ther Apher Dial"},{"issue":"8","key":"10.1016\/j.ebiom.2019.07.003_bb0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1399-3046.2006.00585.x","article-title":"Current role of liver transplantation for methylmalonic acidemia: a review of the literature","volume":"10","author":"Kasahara","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0050","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jpeds.2015.01.051","article-title":"Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantation","volume":"166","author":"Niemi","year":"2015","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.ebiom.2019.07.003_bb0055","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.25304","article-title":"Liver transplantation for propionic Acidemia and Methylmalonic Acidemia: perioperative management and clinical outcomes","volume":"24","author":"Critelli","year":"2018","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ebiom.2019.07.003_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1399-3046.2009.01227.x","article-title":"Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation","volume":"14","author":"Chen","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","article-title":"Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo","volume":"109","author":"Kauffman","year":"2016","journal-title":"Biomaterials."},{"issue":"11","key":"10.1016\/j.ebiom.2019.07.003_bb0080","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett"},{"issue":"10","key":"10.1016\/j.ebiom.2019.07.003_bb0085","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2019.07.003_bb0090","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2019.07.003_bb0095","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.celrep.2017.11.081","article-title":"Systemic messenger RNA therapy as a treatment for Methylmalonic Acidemia","volume":"21","author":"An","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2019.07.003_bb0100","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2019.07.003_bb0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2017.12.024","article-title":"Targeted mRNA therapy for ornithine Transcarbamylase deficiency","volume":"26","author":"Prieve","year":"2018","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2019.07.003_bb0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ymthe.2018.01.006","article-title":"G6PC mRNA therapy positively regulates fasting blood glucose and decreases liver abnormalities in a mouse model of glycogen storage disease 1a","volume":"26","author":"Roseman","year":"2018","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2019.07.003_bb0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2019.07.003_bb0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA therapy for the treatment of Fabry disease: preclinical studies in wild-type mice, Fabry mouse model, and wild-type non-human primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.ebiom.2019.07.003_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"28","key":"10.1016\/j.ebiom.2019.07.003_bb0140","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J Phys Chem B"},{"issue":"4","key":"10.1016\/j.ebiom.2019.07.003_bb0145","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1096\/fj.08-121848","article-title":"Mitochondrial dysfunction in Mut methylmalonic acidemia","volume":"23","author":"Chandler","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2350-8-24","article-title":"Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes","volume":"8","author":"Chandler","year":"2007","journal-title":"BMC Med Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2019.07.003_bb0155","first-page":"248","article-title":"Muscle targeted transgene expression rescues the lethal phenotype of Mut knockout mice","volume":"102","author":"Manoli","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0160","first-page":"S107","article-title":"C.P. V. Partial deficiency model of MUT Methylmalonic Acidemia (MMA) displays diet inducible disease and sensitivity to acetaminophen (APAP)","volume":"21","author":"Senac","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2350-8-64","article-title":"Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle","volume":"8","author":"Chandler","year":"2007","journal-title":"BMC Med Genet"},{"issue":"11","key":"10.1016\/j.ebiom.2019.07.003_bb0170","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1373\/clinchem.2010.148957","article-title":"Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry","volume":"56","author":"Turgeon","year":"2010","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.ebiom.2019.07.003_bb0175","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1373\/clinchem.2007.099226","article-title":"Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry","volume":"54","author":"Minkler","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2091-14-25","article-title":"Optimization and validation of a reversed-phase high performance liquid chromatography method for the measurement of bovine liver methylmalonyl-coenzyme a mutase activity","volume":"14","author":"Ouattara","year":"2013","journal-title":"BMC Biochem"},{"issue":"11","key":"10.1016\/j.ebiom.2019.07.003_bb0185","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00467-014-2847-y","article-title":"Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney","volume":"29","author":"Zsengeller","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0190","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype","volume":"38","author":"Kolker","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2019.07.003_bb0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ymgme.2018.01.009","article-title":"Long-term liver disease in methylmalonic and propionic acidemias","volume":"123","author":"Imbard","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1203\/PDR.0b013e3181a7c270","article-title":"Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria","volume":"66","author":"de Keyzer","year":"2009","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.ebiom.2019.07.003_bb0205","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neuint.2004.03.006","article-title":"Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid","volume":"45","author":"Schuck","year":"2004","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.ebiom.2019.07.003_bb0210","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.imbio.2013.04.008","article-title":"Chronic administration of methylmalonate on young rats alters neuroinflammatory markers and spatial memory","volume":"218","author":"Ribeiro","year":"2013","journal-title":"Immunobiology."},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijdevneu.2005.10.005","article-title":"Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues","volume":"24","author":"Pettenuzzo","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ebiom.2019.07.003_bb0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-8-4","article-title":"Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures","volume":"8","author":"Jafari","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jnc.13544","article-title":"2-Methylcitric acid impairs glutamate metabolism and induces permeability transition in brain mitochondria","volume":"137","author":"Amaral","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10863-011-9324-0","article-title":"Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies","volume":"43","author":"Wajner","year":"2011","journal-title":"J Bioenerg Biomembr"},{"issue":"6","key":"10.1016\/j.ebiom.2019.07.003_bb0235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1212\/01.wnl.0000176065.80560.26","article-title":"Impaired energy metabolism and abnormal muscle histology in Mut- methylmalonic aciduria","volume":"65","author":"Ostergaard","year":"2005","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.ebiom.2019.07.003_bb0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/01913123.2014.921657","article-title":"Abnormal hepatocellular mitochondria in methylmalonic acidemia","volume":"38","author":"Wilnai","year":"2014","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.07.003_bb0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-007-0571-5","article-title":"Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach","volume":"31","author":"Morath","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2019.07.003_bb0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2006.04.003","article-title":"Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency","volume":"88","author":"Kaplan","year":"2006","journal-title":"Mol Genet Metab"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:52:07Z","timestamp":1762455127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419304384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"alternative-id":["S2352396419304384"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.003","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}